Profil
Michael K.
Wilhelm is the founder of Foresight Capital Corp.
He is currently the President & Chief Executive Officer of IR Biosciences Holdings, Inc. since 2015 and the President, Chief Executive Officer & Director of ImmuneRegen BioSciences, Inc. since 2011.
Aktive Positionen von Michael K. Wilhelm
| Unternehmen | Position | Beginn |
|---|---|---|
| IR BIOSCIENCES HOLDINGS, INC. | Vorstandsvorsitzender | 01.07.2003 |
ImmuneRegen BioSciences, Inc.
ImmuneRegen BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops immunomodulator to improve pulmonary function and stimulating the human immune system | Vorstandsvorsitzender | 23.12.2004 |
Foresight Capital Corp.
Foresight Capital Corp. Financial ConglomeratesFinance Provides private equity and debt funding services for institutional and private investors | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
IR Biosciences Holdings, Inc.
IR Biosciences Holdings, Inc. BiotechnologyHealth Technology Operates as a development stage biotechnology company | Health Technology |
ImmuneRegen BioSciences, Inc.
ImmuneRegen BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops immunomodulator to improve pulmonary function and stimulating the human immune system | Commercial Services |
Foresight Capital Corp.
Foresight Capital Corp. Financial ConglomeratesFinance Provides private equity and debt funding services for institutional and private investors | Finance |
















